Biotech

All Articles

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still bented on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, ...

Galapagos' stock up as fund presents intent to form its own evolution

.Galapagos is happening under additional stress from real estate investors. Having constructed a 9.9...

Cell- centered Sana gathers first CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of significant management hirings, shootings and...

Allist settles Jacobio $21M, landing task in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has actually bought itself a starring character in China's KRAS mar...

ReNeuron leaving behind AIM substitution after missing fundraising goal

.ReNeuron has participated in the long list of biotechs to leave behind London's goal securities mar...

MBX files for IPO to take challenger to Ascendis in to period 3

.MBX Biosciences has actually included in the current outbreak of IPO filings. The biotech, which su...

FDA increases probing in to Lykos' MDMA tests: WSJ

.For Lykos Therapeutics as well as the provider's prospective MDMA-assisted therapy for trauma (PTSD...

Gene editor Volume giving up 131 workers

.Only times after gene publisher Volume Biosciences declared unrevealed operational slices, a more c...

Repare lays off 25% of personnel as biotech halts preclinical R&ampD

.Repare Therapeutics is giving up a quarter of its workforce as the oncology biotech lessen its own ...

J &amp J apply for FDA permission of $6.5 B autoimmune drug

.Johnson &amp Johnson has gotten an additional measure towards recognizing a profit on its $6.5 bill...